Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2021 / N 1

Цереброваскулярные заболевания и липидный спектр крови
М.А. Быковская, В.А. Аннушкин, О.В. Лагода, К.В. Антонова, А.А. Шабалина, М.М. Танашян

References

1. Piradov MA, Tanashyan MM, Maksimova MYu. Stroke: new technologies of diagnosis and treatment: guidelines for physicians. 3rd ed. Moscow: MEDpress-inform; 2018. 360 p. (In Russian).
2. Tanashyan MM, Lagoda OV, Orlov SV, Telenkova NG, Maksyutkina LN, Petrukhina SYu. Cerebrovascular diseases and metabolic syndrome. Therapeutic Archive 2013;85(10):34-42 (In Russian).
3. Kolomentsev SV, Odinak MM, Voznyuk IA, Tsygan NV, Yanishevskiy SN, Golokhvastov SYu, Andreyev RV, Yemelin AYu, Pometko DV. Ischemic stroke in stationary patient: current view on the problem. Vestnik of Russian Military Medical Academy 2017;2:206-12 (In Russian).
4. Antonova KV, Tanashyan MM, Romantsova TI, Maksimova MYu. Type 2 diabetes mellitus and clinical course of acute stroke. Obesity and Metabolism 2016;13(2):20-4 (In Russian).
5. Linton MF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL, Doran AC, Vickers KC, Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland J, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, editors. The role of lipids and lipoproteins in atherosclerosis. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2019 Jan 3.
6. Hindy G, Engström G, Larsson SC, Traylor M, Markus HS, Melander O, Orho-Melander M; Stroke Genetics Network (SiGN). Role of blood lipids in the development of ischemic stroke and its subtypes: a Mendelian randomization study. Stroke 2018 Apr;49(4):820-7.
7. Kloska A, Malinowska M, Gabig-Cimińska M, Jakóbkiewicz-Banecka J. Lipids and lipid mediators associated with the risk and pathology of ischemic stroke. International Journal of Molecular Sciences 2020 May;21(10):3618.
8. Kolomentsev SV, Voznyuk IA, Odinak MM, Litvinenko IV, Savello AV, Yanishevskiy SN, Tsygan NV, Khlystov YuV. Actual issues of clinical diagnosis of intrahospital ischemic stroke. Vestnik of Russian Military Medical Academy 2017;3:98-104 (In Russian).
9. Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, Marcovina SM, Nash SD, O’Brien KD, Weintraub WS, Xu P, Zhao XQ, Boden WE. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic syndrome with low HDL/High triglycerides and Impact on Global Health outcomes). Journal of the American College of Cardiology 2013 Oct;62(17):1580-4.
10. Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J, Furberg CD. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circulation: Cardiovascular Quality and Outcomes 2011 May;4(3):337-45.
11. Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, Kahn J, Afonso L, Williams KA Sr, Flack JM. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. Journal of the American College of Cardiology 2012 Dec;60(25):2631-9.
12. Castilla-Guerra L, Del Carmen Fernandez-Moreno M, Colmenero-Camacho MA. Statins in stroke prevention: present and future. Current Pharmaceutical Design 2016;22(30):4638-44.
13. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000 Sep;102(10):1082-5.
14. Dubé JB, Boffa MB, Hegele RA, Koschinsky M. Lipoprotein(a): more interesting than ever after 50 years. Current Opinion in Lipidology 2012 Apr;23(2):133-40.
15. Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, Baum SJ, Steinhagen-Thiessen E, Shapiro MD, Stroes ES, Moriarty PM, Nordestgaard BG, Xia S, Guerriero J, Viney NJ, O’Dea L, Witztum JL; AKCEA-APO(a)-LRx Study Investigators. Lipoprotein(a) reduction in persons with cardiovascular disease. The New England Journal of Medicine 2020 Jan;382(3):244-55.
16. Nave AH, von Eckardstein A. Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism? Clinical Research in Cardiology. Supplements 2019 Apr;14(Suppl 1):28-32.
17. Jin J, Zhang H, Cao Y, Liu HH, Hua Q, Li YF, Zhang Y, Wu NQ, Zhu CG, Xu RX, Gao Y, Li XL, Cui CJ, Liu G, Sun J, Dong Q, Guo YL, Li JJ. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study. Cardiovascular Diabetology 2020 Apr;19(1):45.
18. Dzhanayeva EF, Shemetova GN, Shirshova SA. Pathogenetic bases and modern approaches to early diagnosis of atherosclerosis. Fundamental Research 2012;4:264-9 (In Russian).
19. German CA, Shapiro MD. Atherosclerotic cardiovascular disease risk with advanced lipid testing: state of the science. European Cardiology Review 2020 Jul;15:e56.
20. Antonova KV, Medvedev RB, Shabalina AA, Lagoda OV, Tanashyan MM. Carbohydrate metabolism disorders and cerebral atherosclerosis in patients with ischemic disorders of cerebral circulation. Annals of Clinical and Experimental Neurology 2016;10(1):20-6 (In Russian).
21. Singh P, Zhang Y, Sharma P, Covassin N, Soucek F, Friedman PA, Somers VK. Statins decrease leptin expression in human white adipocytes. Physiological Reports 2018 Jan;6(2):e13566.
22. Lorenzatti AJ, Toth PP. New perspectives on atherogenic dyslipidaemia and cardiovascular disease. European Cardiology 2020 Feb;15:1-9.
23. Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, Schwartz GG, Olsson AG, Colhoun HM, Kronenberg F, Drechsler C, Wanner C, Mora S, Lesogor A, Tsimikas S. Baseline and on-statin treatment lipoprotein(а) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials. The Lancet 2018 Oct;392(10155):1311-20.
24. Enas EA, Varkey B, Dharmarajan TS, Pare G, Bahl VK. Lipoprotein(a): an independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. Indian Heart Journal 2019 Mar-Apr;71(2):99-112.
25. Mazhar Z, Hughes A, Garelnabi M. Targeting the role of lipoprotein (a) in stroke. Cardiovascular & Hematological Disorders. Drug Targets 2017;17(1):64-72.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]